Transcatheter Heart Valve Market, By Product Type (TAVR, TMVR), By Delivery Systems (Transfemoral Approach, Transapical Approach, Transaortic Approach), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratory), and By Regio

Transcatheter Heart Valve Market, By Product Type (TAVR, TMVR), By Delivery Systems (Transfemoral Approach, Transapical Approach, Transaortic Approach), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratory), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Transcatheter heart valve implantation is a minimally-invasive procedure to repair damaged heart valves with bio-prosthetic valves for treatment of valvular heart disease (VHD). It is an alternative approach to conventional open heart surgery and is especially recommended for extremely high risk patients. TAVR is approved by the US FDA for treating individuals suffering from symptomatic aortic stenosis and are at high risk for standard valve replacement surgery. Increasing demand for minimally-invasive procedures is expected to boost growth of the global transcatheter heart valve market over the forecast period

Key features of the study:

• This report provides in-depth analysis of the Transcatheter Heart Valve market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global Transcatheter Heart Valve market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott, JenaValve Technology, SYMETIS, and Braile Biomedica.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Transcatheter Heart Valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Transcatheter Heart Valve market

Detailed Segmentation:

Segmentation

• Transcatheter Heart Valve Market, By Product Type:
• TAVR
• TMVR
• Transcatheter Heart Valve Market, By Delivery Systems:
• Transfemoral Approach
• Transapical Approach
• Transaortic Approach
• Transcatheter Heart Valve Market, By End User:
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratory
• Transcatheter Heart Valve Market, By Region:
• North America
• By Product Type:
• TAVR
• TMVR
• By Delivery Systems
• Transfemoral Approach
• Transapical Approach
• Transaortic Approach
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratory
• By Country:
• U.S.
• Canada
• Latin America
• By Product Type:
• TAVR
• TMVR
• By Delivery Systems
• Transfemoral Approach
• Transapical Approach
• Transaortic Approach
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratory
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Product Type:
• TAVR
• TMVR
• By Delivery Systems
• Transfemoral Approach
• Transapical Approach
• Transaortic Approach
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratory
• By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Product Type:
• TAVR
• TMVR
• By Delivery Systems
• Transfemoral Approach
• Transapical Approach
• Transaortic Approach
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratory
• By Country:
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Product Type:
• TAVR
• TMVR
• By Delivery Systems
• Transfemoral Approach
• Transapical Approach
• Transaortic Approach
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratory
• By Country:
• GCC
• Israel
• Rest of Middle East
• Africa
• By Product Type:
• TAVR
• TMVR
• By Delivery Systems
• Transfemoral Approach
• Transapical Approach
• Transaortic Approach
• By End User:
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratory
• By Country:
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Edwards Lifesciences Corporation*
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Medtronic
• Boston Scientific Corporation
• Abbott
• JenaValve Technology
• SYMETIS
• Braile Biomedica

“*” marked represents similar segmentation in other categories in the respective section.